_id
6915fdb8bc934aba376b281c
Ticker
SPRO
Name
Spero Therapeutics Inc
Exchange
NASDAQ
Address
675 Massachusetts Avenue, Cambridge, MA, United States, 02139
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://sperotherapeutics.com
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candidate for first-line treatment of nontuberculous mycobacterial (NTM) pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to the oral prodrug SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Last Close
2.35
Volume
364117
Current Price
2.32
Change
-1.2765957446808616
Last Updated
2025-12-04T13:27:26.335Z
Image
data:image/webp;base64,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
Ipo Date
2017-11-02T00:00:00.000Z
Market Cap
128453592
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.49
Sentiment Sources
2
Rating
3.3333
Target Price
4
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
3048000
Cost Of Revenue
-
Gross Profit
3048000
Operating Expenses
10964000
Operating Income
-7916000
Interest Expense
-
Pretax Income
-7382000
Net Income
-7382000
Eps
-0.13116363358019292
Dividends Per Share
-
Shares Outstanding
56339295
Income Tax Expense
-
EBITDA
-7382000
Operating Margin
-259.71128608923885
Total Other Income Expense Net
534000
Cash
48616000
Short Term Investments
-
Receivables
2459000
Inventories
-
Total Current Assets
52323000
Property Plant Equipment
1694000
Total Assets
54170000
Payables
1395000
Short Term Debt
1899000
Long Term Debt
-
Total Liabilities
27676000
Equity
26494000
Depreciation
0
Change In Working Capital
22886000
Cash From Operations
17422000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
17422000
PE
-
PB
4.928344458367932
ROE
-27.862912357514908
ROA
-13.627469078825918
FCF
17422000
Fcf Percent
5.715879265091863
Piotroski FScore
2
Health Score
39
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
3
Growth Investing Score
2.5
Momentum Investing Score
4.5
Net Net Investing Score
4.5
Quality Investing Score
3.5
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
3048000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
3048000
Quarters > 0 > income Statement > operating Expenses
10964000
Quarters > 0 > income Statement > operating Income
-7916000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7382000
Quarters > 0 > income Statement > net Income
-7382000
Quarters > 0 > income Statement > eps
-0.13116363358019292
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
56280844
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7382000
Quarters > 0 > income Statement > operating Margin
-259.71128608923885
Quarters > 0 > income Statement > total Other Income Expense Net
534000
Quarters > 0 > balance Sheet > cash
48616000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
2459000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
52323000
Quarters > 0 > balance Sheet > property Plant Equipment
1694000
Quarters > 0 > balance Sheet > total Assets
54170000
Quarters > 0 > balance Sheet > payables
1395000
Quarters > 0 > balance Sheet > short Term Debt
1899000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27676000
Quarters > 0 > balance Sheet > equity
26494000
Quarters > 0 > cash Flow > net Income
-7382000
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
22886000
Quarters > 0 > cash Flow > cash From Operations
17422000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
17422000
Quarters > 0 > ratios > PE
-0.13116363358019292
Quarters > 0 > ratios > PB
4.928344458367932
Quarters > 0 > ratios > ROE
-27.862912357514908
Quarters > 0 > ratios > ROA
-13.627469078825918
Quarters > 0 > ratios > FCF
17422000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
5.715879265091863
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
11802000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
11802000
Quarters > 1 > income Statement > operating Expenses
14246000
Quarters > 1 > income Statement > operating Income
-2444000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-1700000
Quarters > 1 > income Statement > net Income
-1700000
Quarters > 1 > income Statement > eps
-0.030342639617238668
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
56026767
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2361000
Quarters > 1 > income Statement > operating Margin
-20.708354516183697
Quarters > 1 > income Statement > total Other Income Expense Net
744000
Quarters > 1 > balance Sheet > cash
31194000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
24453000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
59402000
Quarters > 1 > balance Sheet > property Plant Equipment
2564000
Quarters > 1 > balance Sheet > total Assets
62119000
Quarters > 1 > balance Sheet > payables
780000
Quarters > 1 > balance Sheet > short Term Debt
1844000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
29291000
Quarters > 1 > balance Sheet > equity
32828000
Quarters > 1 > cash Flow > net Income
-1700000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-16985000
Quarters > 1 > cash Flow > cash From Operations
-17693000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-17693000
Quarters > 1 > ratios > PE
-0.030342639617238668
Quarters > 1 > ratios > PB
3.959488833922261
Quarters > 1 > ratios > ROE
-5.178506153283783
Quarters > 1 > ratios > ROA
-2.7366828184613405
Quarters > 1 > ratios > FCF
-17693000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-1.4991526859854263
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
5874000
Quarters > 2 > income Statement > cost Of Revenue
13606000
Quarters > 2 > income Statement > gross Profit
-7732000
Quarters > 2 > income Statement > operating Expenses
6999000
Quarters > 2 > income Statement > operating Income
-14731000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-13866000
Quarters > 2 > income Statement > net Income
-13866000
Quarters > 2 > income Statement > eps
-0.2503964339329388
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
55376188
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-14555500
Quarters > 2 > income Statement > operating Margin
-250.78311201906706
Quarters > 2 > income Statement > total Other Income Expense Net
865000
Quarters > 2 > balance Sheet > cash
48887000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
24279000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
74714000
Quarters > 2 > balance Sheet > property Plant Equipment
2842000
Quarters > 2 > balance Sheet > total Assets
77709000
Quarters > 2 > balance Sheet > payables
1765000
Quarters > 2 > balance Sheet > short Term Debt
1795000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
43895000
Quarters > 2 > balance Sheet > equity
33814000
Quarters > 2 > cash Flow > net Income
-13866000
Quarters > 2 > cash Flow > depreciation
500
Quarters > 2 > cash Flow > change In Working Capital
8035000
Quarters > 2 > cash Flow > cash From Operations
-4002000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-4002000
Quarters > 2 > ratios > PE
-0.2503964339329388
Quarters > 2 > ratios > PB
3.7993954030874786
Quarters > 2 > ratios > ROE
-41.00668362216833
Quarters > 2 > ratios > ROA
-17.84349303169517
Quarters > 2 > ratios > FCF
-4002000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.6813074565883555
Quarters > 2 > health Score
20
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
15044000
Quarters > 3 > income Statement > cost Of Revenue
94634000
Quarters > 3 > income Statement > gross Profit
-79590000
Quarters > 3 > income Statement > operating Expenses
-57865000
Quarters > 3 > income Statement > operating Income
-21725000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-20598000
Quarters > 3 > income Statement > net Income
-20888000
Quarters > 3 > income Statement > eps
-0.3865433969262731
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
54037917
Quarters > 3 > income Statement > income Tax Expense
290000
Quarters > 3 > income Statement > EBITDA
-20848000
Quarters > 3 > income Statement > operating Margin
-144.40973145440043
Quarters > 3 > income Statement > total Other Income Expense Net
1127000
Quarters > 3 > balance Sheet > cash
52889000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
52476000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
107276000
Quarters > 3 > balance Sheet > property Plant Equipment
3114000
Quarters > 3 > balance Sheet > total Assets
110543000
Quarters > 3 > balance Sheet > payables
7306000
Quarters > 3 > balance Sheet > short Term Debt
1746000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
64420000
Quarters > 3 > balance Sheet > equity
46123000
Quarters > 3 > cash Flow > net Income
-20888000
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
-4284000
Quarters > 3 > cash Flow > cash From Operations
-23401000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
0
Quarters > 3 > cash Flow > net Change In Cash
-23401000
Quarters > 3 > ratios > PE
-0.3865433969262731
Quarters > 3 > ratios > PB
2.718122573119701
Quarters > 3 > ratios > ROE
-45.287600546365155
Quarters > 3 > ratios > ROA
-18.895814298508274
Quarters > 3 > ratios > FCF
-23401000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-1.5555038553576177
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
47977000
Annuals > 0 > income Statement > cost Of Revenue
96757000
Annuals > 0 > income Statement > gross Profit
-48780000
Annuals > 0 > income Statement > operating Expenses
24581000
Annuals > 0 > income Statement > operating Income
-73361000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-68566000
Annuals > 0 > income Statement > net Income
-68566000
Annuals > 0 > income Statement > eps
-1.2688497967084853
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
54037917
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-72482000
Annuals > 0 > income Statement > operating Margin
-152.9086854117598
Annuals > 0 > income Statement > total Other Income Expense Net
4795000
Annuals > 0 > balance Sheet > cash
52889000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
52476000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
107276000
Annuals > 0 > balance Sheet > property Plant Equipment
3114000
Annuals > 0 > balance Sheet > total Assets
110543000
Annuals > 0 > balance Sheet > payables
7306000
Annuals > 0 > balance Sheet > short Term Debt
1746000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
64420000
Annuals > 0 > balance Sheet > equity
46123000
Annuals > 0 > cash Flow > net Income
-68566000
Annuals > 0 > cash Flow > depreciation
2000
Annuals > 0 > cash Flow > change In Working Capital
36284000
Annuals > 0 > cash Flow > cash From Operations
-23444000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
0
Annuals > 0 > cash Flow > net Change In Cash
-23444000
Annuals > 0 > ratios > PE
-1.2688497967084853
Annuals > 0 > ratios > PB
2.671258390824534
Annuals > 0 > ratios > ROE
-148.65902044533098
Annuals > 0 > ratios > ROA
-62.02654170775174
Annuals > 0 > ratios > FCF
-23444000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.4886508118473435
Annuals > 0 > health Score
24
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
103781000
Annuals > 1 > income Statement > cost Of Revenue
51440000
Annuals > 1 > income Statement > gross Profit
52341000
Annuals > 1 > income Statement > operating Expenses
30860000
Annuals > 1 > income Statement > operating Income
21481000
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
25404000
Annuals > 1 > income Statement > net Income
22806000
Annuals > 1 > income Statement > eps
0.4303909696025762
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
52989030
Annuals > 1 > income Statement > income Tax Expense
2598000
Annuals > 1 > income Statement > EBITDA
27154000
Annuals > 1 > income Statement > operating Margin
20.698393732956898
Annuals > 1 > income Statement > total Other Income Expense Net
3923000
Annuals > 1 > balance Sheet > cash
76333000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
50697000
Annuals > 1 > balance Sheet > inventories
1
Annuals > 1 > balance Sheet > total Current Assets
131208000
Annuals > 1 > balance Sheet > property Plant Equipment
4157000
Annuals > 1 > balance Sheet > total Assets
182390000
Annuals > 1 > balance Sheet > payables
1378000
Annuals > 1 > balance Sheet > short Term Debt
1718000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
75496000
Annuals > 1 > balance Sheet > equity
106894000
Annuals > 1 > cash Flow > net Income
22806000
Annuals > 1 > cash Flow > depreciation
367000
Annuals > 1 > cash Flow > change In Working Capital
-70375000
Annuals > 1 > cash Flow > cash From Operations
-32995000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
221000
Annuals > 1 > cash Flow > net Change In Cash
-32774000
Annuals > 1 > ratios > PE
0.4303909696025762
Annuals > 1 > ratios > PB
1.1302317099182366
Annuals > 1 > ratios > ROE
21.33515445207402
Annuals > 1 > ratios > ROA
12.50397499862931
Annuals > 1 > ratios > FCF
-32995000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.31792910070244074
Annuals > 1 > health Score
70
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
48579000
Annuals > 2 > income Statement > cost Of Revenue
1547000
Annuals > 2 > income Statement > gross Profit
48579000
Annuals > 2 > income Statement > operating Expenses
90776000
Annuals > 2 > income Statement > operating Income
-42197000
Annuals > 2 > income Statement > interest Expense
2605000
Annuals > 2 > income Statement > pretax Income
-46415000
Annuals > 2 > income Statement > net Income
-46415000
Annuals > 2 > income Statement > eps
-1.2349316849839995
Annuals > 2 > income Statement > dividends Per Share
54485000
Annuals > 2 > income Statement > shares Outstanding
37585075
Annuals > 2 > income Statement > income Tax Expense
1613000
Annuals > 2 > income Statement > EBITDA
-42941000
Annuals > 2 > income Statement > operating Margin
-86.86263611848742
Annuals > 2 > income Statement > total Other Income Expense Net
-4218000
Annuals > 2 > balance Sheet > cash
109107000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
1084000
Annuals > 2 > balance Sheet > inventories
-4463000
Annuals > 2 > balance Sheet > total Current Assets
109107000
Annuals > 2 > balance Sheet > property Plant Equipment
5492000
Annuals > 2 > balance Sheet > total Assets
124802000
Annuals > 2 > balance Sheet > payables
617000
Annuals > 2 > balance Sheet > short Term Debt
1690000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
48868000
Annuals > 2 > balance Sheet > equity
75934000
Annuals > 2 > cash Flow > net Income
-46415000
Annuals > 2 > cash Flow > depreciation
1547000
Annuals > 2 > cash Flow > change In Working Capital
22087000
Annuals > 2 > cash Flow > cash From Operations
-7731000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
33807000
Annuals > 2 > cash Flow > cash From Financing
-29553000
Annuals > 2 > cash Flow > net Change In Cash
-3477000
Annuals > 2 > ratios > PE
-1.2349316849839995
Annuals > 2 > ratios > PB
1.1285322912002527
Annuals > 2 > ratios > ROE
-61.1254510495957
Annuals > 2 > ratios > ROA
-37.19091040207689
Annuals > 2 > ratios > FCF
-7731000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.15914283949854877
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3070000
Annuals > 3 > income Statement > cost Of Revenue
1117000
Annuals > 3 > income Statement > gross Profit
3070000
Annuals > 3 > income Statement > operating Expenses
91041000
Annuals > 3 > income Statement > operating Income
-87971000
Annuals > 3 > income Statement > interest Expense
1940000
Annuals > 3 > income Statement > pretax Income
-89756000
Annuals > 3 > income Statement > net Income
-89756000
Annuals > 3 > income Statement > eps
-2.905123927053282
Annuals > 3 > income Statement > dividends Per Share
47480000
Annuals > 3 > income Statement > shares Outstanding
30895756
Annuals > 3 > income Statement > income Tax Expense
1545000
Annuals > 3 > income Statement > EBITDA
-87170000
Annuals > 3 > income Statement > operating Margin
-2865.5048859934855
Annuals > 3 > income Statement > total Other Income Expense Net
-1785000
Annuals > 3 > balance Sheet > cash
112584000
Annuals > 3 > balance Sheet > short Term Investments
33818000
Annuals > 3 > balance Sheet > receivables
2641000
Annuals > 3 > balance Sheet > inventories
-361000
Annuals > 3 > balance Sheet > total Current Assets
157872000
Annuals > 3 > balance Sheet > property Plant Equipment
7556000
Annuals > 3 > balance Sheet > total Assets
171072000
Annuals > 3 > balance Sheet > payables
1101000
Annuals > 3 > balance Sheet > short Term Debt
1362000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
82783000
Annuals > 3 > balance Sheet > equity
88289000
Annuals > 3 > cash Flow > net Income
-89756000
Annuals > 3 > cash Flow > depreciation
1117000
Annuals > 3 > cash Flow > change In Working Capital
12862000
Annuals > 3 > cash Flow > cash From Operations
-64346999
Annuals > 3 > cash Flow > capital Expenditures
64346999
Annuals > 3 > cash Flow > cash From Investing
7672000
Annuals > 3 > cash Flow > cash From Financing
84050000
Annuals > 3 > cash Flow > net Change In Cash
27375000
Annuals > 3 > ratios > PE
-2.905123927053282
Annuals > 3 > ratios > PB
0.7978607038249385
Annuals > 3 > ratios > ROE
-101.66158864637724
Annuals > 3 > ratios > ROA
-52.4667976056865
Annuals > 3 > ratios > FCF
-128693998
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-41.91986905537459
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.13116363358019292
Valuation > metrics > PB
4.928344458367932
Valuation > final Score
30.716555416320677
Valuation > verdict
64.3% Overvalued
Profitability > metrics > ROE
-27.862912357514908
Profitability > metrics > ROA
-14.108518242455517
Profitability > metrics > Net Margin
-2.4219160104986877
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.0446138748395863
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.884335154826958
Liquidity > metrics > Quick Ratio
15.884335154826958
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
40.40511166077739
Prev Valuations > 1
42.00604596912521
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
33
Prev Risks > 1
-55
Prev Risks > 2
-318
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:13:46.503Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-17
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.13
Earnings History > 0 > eps Estimate
-0.39
Earnings History > 0 > eps Difference
0.26
Earnings History > 0 > surprise Percent
66.6667
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.03
Earnings History > 1 > eps Estimate
-0.57
Earnings History > 1 > eps Difference
0.54
Earnings History > 1 > surprise Percent
94.7368
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.2472
Earnings History > 2 > eps Estimate
-0.55
Earnings History > 2 > eps Difference
0.3028
Earnings History > 2 > surprise Percent
55.0545
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-11
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.3669
Earnings History > 3 > eps Estimate
-0.31
Earnings History > 3 > eps Difference
-0.0569
Earnings History > 3 > surprise Percent
-18.3548
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.32
Earnings History > 4 > eps Estimate
-0.5
Earnings History > 4 > eps Difference
0.18
Earnings History > 4 > surprise Percent
36
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-05
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.33
Earnings History > 5 > eps Estimate
-0.38
Earnings History > 5 > eps Difference
0.05
Earnings History > 5 > surprise Percent
13.1579
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.24
Earnings History > 6 > eps Estimate
-0.04
Earnings History > 6 > eps Difference
-0.2
Earnings History > 6 > surprise Percent
-500
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-13
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.96
Earnings History > 7 > eps Estimate
-0.1
Earnings History > 7 > eps Difference
1.06
Earnings History > 7 > surprise Percent
1060
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.04
Earnings History > 8 > eps Estimate
-0.03
Earnings History > 8 > eps Difference
0.07
Earnings History > 8 > surprise Percent
233.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.23
Earnings History > 9 > eps Estimate
-0.34
Earnings History > 9 > eps Difference
0.11
Earnings History > 9 > surprise Percent
32.3529
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.25
Earnings History > 10 > eps Estimate
-0.33
Earnings History > 10 > eps Difference
0.08
Earnings History > 10 > surprise Percent
24.2424
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.55
Earnings History > 11 > eps Estimate
0.04
Earnings History > 11 > eps Difference
0.51
Earnings History > 11 > surprise Percent
1275
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.33
Earnings History > 12 > eps Estimate
-0.3
Earnings History > 12 > eps Difference
-0.03
Earnings History > 12 > surprise Percent
-10
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-10
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.87
Earnings History > 13 > eps Estimate
-0.93
Earnings History > 13 > eps Difference
0.06
Earnings History > 13 > surprise Percent
6.4516
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-1.01
Earnings History > 14 > eps Estimate
-0.87
Earnings History > 14 > eps Difference
-0.14
Earnings History > 14 > surprise Percent
-16.092
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-31
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.9
Earnings History > 15 > eps Estimate
-0.75
Earnings History > 15 > eps Difference
-0.15
Earnings History > 15 > surprise Percent
-20
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-10
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.7
Earnings History > 16 > eps Estimate
-0.66
Earnings History > 16 > eps Difference
-0.04
Earnings History > 16 > surprise Percent
-6.0606
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.63
Earnings History > 17 > eps Estimate
-0.75
Earnings History > 17 > eps Difference
0.12
Earnings History > 17 > surprise Percent
16
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.66
Earnings History > 18 > eps Estimate
-0.64
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-3.125
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-11
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.68
Earnings History > 19 > eps Estimate
-0.74
Earnings History > 19 > eps Difference
0.06
Earnings History > 19 > surprise Percent
8.1081
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-05
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.86
Earnings History > 20 > eps Estimate
-0.87
Earnings History > 20 > eps Difference
0.01
Earnings History > 20 > surprise Percent
1.1494
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-06
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.85
Earnings History > 21 > eps Estimate
-1.12
Earnings History > 21 > eps Difference
0.27
Earnings History > 21 > surprise Percent
24.1071
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-08
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1.19
Earnings History > 22 > eps Estimate
-1.25
Earnings History > 22 > eps Difference
0.06
Earnings History > 22 > surprise Percent
4.8
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-16
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-1.32
Earnings History > 23 > eps Estimate
-1.08
Earnings History > 23 > eps Difference
-0.24
Earnings History > 23 > surprise Percent
-22.2222
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-04
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.95
Earnings History > 24 > eps Estimate
-0.85
Earnings History > 24 > eps Difference
-0.1
Earnings History > 24 > surprise Percent
-11.7647
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-08
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.74
Earnings History > 25 > eps Estimate
-0.65
Earnings History > 25 > eps Difference
-0.09
Earnings History > 25 > surprise Percent
-13.8462
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-09
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.29
Earnings History > 26 > eps Estimate
-0.78
Earnings History > 26 > eps Difference
0.49
Earnings History > 26 > surprise Percent
62.8205
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-14
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.6
Earnings History > 27 > eps Estimate
-0.75
Earnings History > 27 > eps Difference
0.15
Earnings History > 27 > surprise Percent
20
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-08
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.6
Earnings History > 28 > eps Estimate
-0.63
Earnings History > 28 > eps Difference
0.03
Earnings History > 28 > surprise Percent
4.7619
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-09
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.69
Earnings History > 29 > eps Estimate
-0.77
Earnings History > 29 > eps Difference
0.08
Earnings History > 29 > surprise Percent
10.3896
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-05-10
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.74
Earnings History > 30 > eps Estimate
-1.2
Earnings History > 30 > eps Difference
0.46
Earnings History > 30 > surprise Percent
38.3333
Earnings History > 31 > period
2017-09-30
Earnings History > 31 > report Date
2017-12-14
Earnings History > 31 > date
2017-09-30
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-36.02
Earnings History > 31 > eps Estimate
-2.43
Earnings History > 31 > eps Difference
-33.59
Earnings History > 31 > surprise Percent
-1382.3045
Earnings History > 32 > period
2017-06-30
Earnings History > 32 > report Date
2017-08-30
Earnings History > 32 > date
2017-06-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-2.96
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
-2.96
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-03-31
Earnings History > 33 > report Date
2017-05-04
Earnings History > 33 > date
2017-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.51
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.51
Earnings History > 33 > surprise Percent
-
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil hydrobromide), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adult patients, which is in Phase 3 development; and SPR720, a novel product candidate for first-line treatment of nontuberculous mycobacterial (NTM) pulmonary disease. It has license agreement with Meiji Seika Pharma Co., Ltd. to support the development of tebipenem HBr; Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; and Vertex Pharmaceuticals Incorporated for patents relating to the oral prodrug SPR720, as well as SPR719, an active metabolite. Spero Therapeutics, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ASpero Therapeutics (NASDAQ:SPRO) Upgraded to "Buy" at Wall Street Zen MarketBeat
Read more →Spero Therapeutics (NASDAQ:SPRO) Stock Rating Lowered by Wall Street Zen Defense World
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$4
Analyst Picks
Strong Buy
0
Buy
1
Hold
2
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 24.52% of the total shares of Spero Therapeutics Inc
1.
Pfizer Inc(4.1978%)
since
2025/06/30
2.
Vanguard Group Inc(3.4658%)
since
2025/06/30
3.
Anson Funds Management LP(2.8707%)
since
2025/06/30
4.
Vanguard Total Stock Mkt Idx Inv(2.0274%)
since
2025/07/31
5.
Alphabet Inc(1.5815%)
since
2025/06/30
6.
Renaissance Technologies Corp(1.4787%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.9171%)
since
2025/07/31
8.
Schonfeld Strategic Advisors LLC(0.9077%)
since
2025/06/30
9.
Geode Capital Management, LLC(0.9075%)
since
2025/06/30
10.
BlackRock Inc(0.7726%)
since
2025/06/30
11.
MONIMUS CAPITAL MANAGEMENT, LP(0.5525%)
since
2025/06/30
12.
IMC US Ultra Micro Cap(0.4537%)
since
2025/07/31
13.
The Informed Momentum Company (formerly EAM Investors)(0.4249%)
since
2025/06/30
14.
Fidelity Extended Market Index(0.42%)
since
2025/07/31
15.
Stonepine Capital Management Llc(0.2788%)
since
2025/06/30
16.
State Street Corp(0.2727%)
since
2025/06/30
17.
Ionic Capital Management LLC(0.2665%)
since
2025/06/30
18.
ADAR1 Capital Management LLC(0.2557%)
since
2025/06/30
19.
Pleiades Small Cap Equity A(0.2269%)
since
2025/06/30
20.
Bridgeway Capital Management, LLC(0.204%)
since
2025/06/30
21.
Fidelity Total Market Index(0.1933%)
since
2025/07/31
22.
Extended Equity Market Fund K(0.1903%)
since
2025/06/30
23.
Citadel Advisors Llc(0.1844%)
since
2025/06/30
24.
Northern Trust Corp(0.1792%)
since
2025/06/30
25.
Susquehanna International Group, LLP(0.1241%)
since
2025/06/30
26.
Bridgeway Ultra-Small Company Market(0.1151%)
since
2025/06/30
27.
JPM Multi-Manager Alt C (acc) USD(0.1073%)
since
2025/07/31
28.
Fidelity Series Total Market Index(0.106%)
since
2025/07/31
29.
Spartan Extended Market Index Pool F(0.0966%)
since
2025/07/31
30.
Northern Trust Extended Eq Market Idx(0.0889%)
since
2025/06/30
31.
NT Ext Equity Mkt Idx Fd - L(0.0889%)
since
2025/06/30
32.
Bridgeway Omni Small-Cap Value N(0.0888%)
since
2025/06/30
33.
Bridgeway Omni Small-Cap Value(0.0888%)
since
2025/06/30
34.
Avantis US Small Cap Equity ETF(0.0676%)
since
2025/08/30
35.
XTX Topco Ltd(0.0614%)
since
2025/06/30
36.
Spartan Total Market Index Pool G(0.0579%)
since
2025/07/31
37.
Axxcess Wealth Management, LLC(0.0578%)
since
2025/06/30
38.
Schwab Total Stock Market Index(0.0508%)
since
2025/07/31
39.
NT Ext Equity Mkt Idx Fd - NL(0.0465%)
since
2025/06/30
40.
Vanguard Instl Ttl Stk Mkt Idx InstlPls(0.0406%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.13
EPS Estimate
-0.39
EPS Difference
0.26
Surprise Percent
66.6667%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.